C. Allal

发表

In vivo and in vitro antitumor activity of oxaliplatin in combination with cetuximab in human colorectal tumor cell lines expressing different level of EGFR

P. Rochaix, P. Canal, D. Balin-Gauthier, 2006, Cancer Chemotherapy and Pharmacology.

Improved oligonucleotide uptake and stability by a new drug carrier, the SupraMolecular Bio Vector (SMBV).

G. Favre, S. Sixou, C. Allal, 1997, Biochimica et biophysica acta.

Salmeterol‐induced desensitization, internalization and phosphorylation of the human β2‐adrenoceptor

B. J. Knoll, A. Seibold, R. Clark, 1998, British journal of pharmacology.

Depression of reticulo‐ruminal motor functions through the stimulation of 012‐adrenoceptors

C. Allal, Y. Ruckebusch, 1987 .

Epidermal growth factor stimulates 3-hydroxy-3-methylglutaryl-coenzyme A reductase expression via the ErbB-2 pathway in human breast adenocarcinoma cells.

G. Favre, C. Allal, A. Pradines, 1999, Biochemical and biophysical research communications.

Technical note: Hapten synthesis, antibody production and development of an enzyme-linked immunosorbent assay for detection of the natural steroidal alkaloid Dendrogenin A.

G. Delsol, M. Poirot, S. Silvente-Poirot, 2013, Biochimie.

RhoB prenylation is driven by the three carboxyl-terminal amino acids of the protein: evidenced in vivo by an anti-farnesyl cysteine antibody.

G. Favre, J. Faye, C. Allal, 2000, Proceedings of the National Academy of Sciences of the United States of America.

The farnesyltransferase inhibitor FTI-277 suppresses the 24-kDa FGF2-induced radioresistance in HeLa cells expressing wild-type RAS.

S. Sebti, E. Cohen-Jonathan, C. Toulas, 1999, Radiation research.

Stable activation and desensitization of beta 2-adrenergic receptor stimulation of adenylyl cyclase by salmeterol: evidence for quasi-irreversible binding to an exosite.

M. Johnson, R. Clark, J. Friedman, 1996, Molecular pharmacology.

SupraMolecular BioVectors (SMBV) improve antisense inhibition of erbB-2 expression.

G. Favre, S. Sixou, C. Allal, 1998, British Journal of Cancer.

Central cardiovascular effects of tacrine in the conscious dog: a role for catecholamines and vasopressin release.

O. Rascol, C. Brefel‐Courbon, C. Gharib, 1998, European journal of pharmacology.

In vivo restoration of RhoB expression leads to ovarian tumor regression

M. Golzio, J. Teissié, G. Favre, 2008, Cancer Gene Therapy.

Selective inhibition of HER2 inhibits AKT signal transduction and prolongs disease-free survival in a micrometastasis model of ovarian carcinoma.

S. Guichard, P. Rochaix, P. Canal, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Geranylgeranylated, but not farnesylated, RhoB suppresses Ras transformation of NIH-3T3 cells.

J. Mazières, S. Sebti, G. Favre, 2005, Experimental cell research.

Farnesylated RhoB Prevents Cell Cycle Arrest and Actin Cytoskeleton Disruption Caused by the Geranylgeranyltransferase I Inhibitor GGTI-298

S. Sebti, G. Favre, A. Hamilton, 2002, Cell cycle.

Human Cytomegalovirus Carries a Cell-Derived Phospholipase A2 Required for Infectivity

C. Claudel-Renard, T. Faraut, M. Record, 2004, Journal of Virology.

Serum protein signature may improve detection of ductal carcinoma in situ of the breast

P. Rouanet, J. Solassol, A. Mangé, 2010, Oncogene.

RhoA Prenylation Is Required for Promotion of Cell Growth and Transformation and Cytoskeleton Organization but Not for Induction of Serum Response Element Transcription*

S. Sebti, G. Favre, A. Hamilton, 2000, The Journal of Biological Chemistry.

Depression of reticulo-ruminal motor functions through the stimulation of alpha 2-adrenoceptors.

C. Allal, Y. Ruckebusch, 1987, Journal of veterinary pharmacology and therapeutics.

Alleviation of excessive gas accumulation in the ruminant stomach by ritanserin.

C. Allal, A. Degryse, L. Ooms, 1985, American Journal of Veterinary Research.